HPV9 vaccine offers broader protection and saves healthcare costs in the long runSince 2022, girls and boys in the Netherlands have been eligible to receive the HPV vaccine, which provides preventive protection against six types of cancer. However, even stronger protection is possible with the more expensive HPV9 vaccine. This version protects against nine strains of the virus, which not only cause cancer but can also lead to genital and respiratory warts. Researchers at Amsterdam UMC have now calculated that investing in this more comprehensive vaccine will pay off over time. It reduces unnecessary suffering as well as the healthcare and screening costs associated with diseases the HPV9 vaccine can prevent. The researchers therefore advocate for the inclusion of HPV9 in the national vaccination program.
In the spotlight June 2025: AI&I Prizes, Grants, and AppointmentsRecently, several prestigious prizes and grants have been awarded to our AI&I members Brent Appelman, Dr. Astrid Hendriks and Prof. Sietze Reitsma. Learn more about these accomplished individuals and their projects in the article below!
Some of these cookies are ‘strictly necessary’, or essential for technical reasons. Others are used to improve the website. We also use cookies to enable the viewing of video material and animations. By opting to “accept cookies”, you agree to the use of all of the cookies described in our cookie policy. Should you choose to “refuse cookies”, only ‘strictly necessary’ and analytics cookies will be placed on your device. You can change your preferences at any time via the cookie policy.
